MA30790B1 - Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique - Google Patents
Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutiqueInfo
- Publication number
- MA30790B1 MA30790B1 MA31786A MA31786A MA30790B1 MA 30790 B1 MA30790 B1 MA 30790B1 MA 31786 A MA31786 A MA 31786A MA 31786 A MA31786 A MA 31786A MA 30790 B1 MA30790 B1 MA 30790B1
- Authority
- MA
- Morocco
- Prior art keywords
- yle
- pyridin
- alkyl
- pyrrolizine
- indolizine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Indole Compounds (AREA)
Abstract
COMPOSÉ RÉPONDANT À LA FORMULE GÉNÉRALE DANS LAQUELLE M ET N REPRÉSENTENT CHACUN LE NOMBRE 1 OU 2, AR REPRÉSENTE UN GROUPE CHOISI PARMI LES GROUPES PHÉNYLE, NAPHTHYLE-1, NAPHTYLE-2, PYRIDIN-2-YLE, PYRIDIN-3-YLE, PYRIDIN-4- YLE, FURAN-2-YLE, FURAN-3 YLE, THIÉN-2-YLE, THIÉN-3-YLE, THIAZOL-2-YLE ET OXAZOL-2-YLE, CE GROUPE AR POUVANT ÊTRE ÉVENTUELLEMENT SUBSTITUÉ; R REPRÉSENTE SOIT UN ATOME D'HYDROGÈNE, SOIT UN OU PLUSIEURS SUBSTITUANTS IDENTIQUES OU DIFFÉRENTS L'UN DE L'AUTRE CHOISIS PARMI LES ATOMES D'HALOGÈNES ET LES GROUPES MONO- OU POLYFLUORO(C1-C6)ALKYLE ET MONO- OU POLYFLUORO(C1-C6)ALKYLOXY, (C1-C6)ALKYLES LINÉAIRES, (C3-C7)ALKYLES RAMIFIÉS OU CYCLIQUES, (C3-C7)CYCLOALKYL(C1-C6)ALKYLE, (C1-C6)ALCOXY, (C3-C7)CYCLOALKYLOXY, (C3-C7)CYCLOALKYL(C1-C6)ALKYLOXY, (C1-C6)ALKYLTHIO, CYANO, AMINO, PHÉNYLE, ACÉTYLE, BENZOYLE, (C1-C6)ALKYLSULFONYLE, CARBOXY, (C1C6)ALCOXYCARBONYLE ETPENTAFLUOROSULFANYLE. APPLICATION EN THÉRAPEUTIQUE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0608348A FR2906251B1 (fr) | 2006-09-22 | 2006-09-22 | Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
MA30790B1 true MA30790B1 (fr) | 2009-10-01 |
Family
ID=37897398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA31786A MA30790B1 (fr) | 2006-09-22 | 2009-04-16 | Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique |
Country Status (29)
Country | Link |
---|---|
US (2) | US7776880B2 (fr) |
EP (1) | EP2077837A2 (fr) |
JP (1) | JP2010504311A (fr) |
KR (1) | KR20090080947A (fr) |
CN (1) | CN101573113A (fr) |
AR (1) | AR062896A1 (fr) |
AU (1) | AU2007301880A1 (fr) |
BR (1) | BRPI0717100A2 (fr) |
CA (1) | CA2663080A1 (fr) |
CL (1) | CL2007002732A1 (fr) |
CO (1) | CO6160309A2 (fr) |
CR (1) | CR10658A (fr) |
EA (1) | EA015974B1 (fr) |
FR (1) | FR2906251B1 (fr) |
GT (1) | GT200900061A (fr) |
HN (1) | HN2009000504A (fr) |
IL (1) | IL197500A0 (fr) |
MA (1) | MA30790B1 (fr) |
ME (1) | MEP10109A (fr) |
MX (1) | MX2009003083A (fr) |
NO (1) | NO20091351L (fr) |
NZ (1) | NZ575573A (fr) |
PE (1) | PE20081376A1 (fr) |
SV (1) | SV2009003191A (fr) |
TN (1) | TN2009000082A1 (fr) |
TW (1) | TW200819455A (fr) |
UY (1) | UY30604A1 (fr) |
WO (1) | WO2008037881A2 (fr) |
ZA (1) | ZA200901850B (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2842804B1 (fr) | 2002-07-29 | 2004-09-03 | Sanofi Synthelabo | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
FR2861074B1 (fr) * | 2003-10-17 | 2006-04-07 | Sanofi Synthelabo | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
CN102405222A (zh) * | 2009-01-28 | 2012-04-04 | 阿斯利康(瑞典)有限公司 | 2-氮杂-二环[2.2.1]庚烷化合物及其用途 |
AR075182A1 (es) * | 2009-01-28 | 2011-03-16 | Astrazeneca Ab | Compuestos 2-aza-biciclo (2.2.2) octano y sus usos |
US8338441B2 (en) | 2009-05-15 | 2012-12-25 | Gilead Sciences, Inc. | Inhibitors of human immunodeficiency virus replication |
US8143273B2 (en) | 2010-06-22 | 2012-03-27 | Hoffman-La Roche Inc. | Quinolizidine and indolizidine derivatives |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3801636A (en) * | 1971-08-13 | 1974-04-02 | Abbott Lab | 3,4,5-tri-substituted cinnamides |
US4409225A (en) * | 1981-03-16 | 1983-10-11 | Beecham Group Limited | Substituted benzamides |
AU2491092A (en) * | 1991-09-12 | 1993-04-05 | Smithkline Beecham Plc | Azabicyclic compounds as 5-ht4 receptor antagonists |
CZ284456B6 (cs) | 1992-02-15 | 1998-12-16 | Hoechst Aktiengesellschaft | Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje |
AU2001292936A1 (en) * | 2000-09-22 | 2002-04-02 | Ortho-Mcneil Pharmaceutical, Inc. | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
FR2861073B1 (fr) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
FR2861076B1 (fr) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique |
-
2006
- 2006-09-22 FR FR0608348A patent/FR2906251B1/fr not_active Expired - Fee Related
-
2007
- 2007-09-13 TW TW096134256A patent/TW200819455A/zh unknown
- 2007-09-19 AR ARP070104135A patent/AR062896A1/es unknown
- 2007-09-20 PE PE2007001267A patent/PE20081376A1/es not_active Application Discontinuation
- 2007-09-21 CN CNA2007800392487A patent/CN101573113A/zh active Pending
- 2007-09-21 WO PCT/FR2007/001545 patent/WO2008037881A2/fr active Application Filing
- 2007-09-21 EA EA200970312A patent/EA015974B1/ru not_active IP Right Cessation
- 2007-09-21 NZ NZ575573A patent/NZ575573A/en not_active IP Right Cessation
- 2007-09-21 UY UY30604A patent/UY30604A1/es not_active Application Discontinuation
- 2007-09-21 CA CA002663080A patent/CA2663080A1/fr not_active Abandoned
- 2007-09-21 KR KR1020097008124A patent/KR20090080947A/ko not_active Application Discontinuation
- 2007-09-21 ME MEP-101/09A patent/MEP10109A/xx unknown
- 2007-09-21 CL CL200702732A patent/CL2007002732A1/es unknown
- 2007-09-21 MX MX2009003083A patent/MX2009003083A/es active IP Right Grant
- 2007-09-21 ZA ZA200901850A patent/ZA200901850B/xx unknown
- 2007-09-21 EP EP07848274A patent/EP2077837A2/fr not_active Withdrawn
- 2007-09-21 BR BRPI0717100-5A patent/BRPI0717100A2/pt not_active IP Right Cessation
- 2007-09-21 JP JP2009528756A patent/JP2010504311A/ja not_active Withdrawn
- 2007-09-21 AU AU2007301880A patent/AU2007301880A1/en not_active Abandoned
-
2009
- 2009-03-09 IL IL197500A patent/IL197500A0/en unknown
- 2009-03-10 TN TN2009000082A patent/TN2009000082A1/fr unknown
- 2009-03-11 CR CR10658A patent/CR10658A/es not_active Application Discontinuation
- 2009-03-16 GT GT200900061A patent/GT200900061A/es unknown
- 2009-03-18 HN HN2009000504A patent/HN2009000504A/es unknown
- 2009-03-19 US US12/407,276 patent/US7776880B2/en not_active Expired - Fee Related
- 2009-03-19 CO CO09028765A patent/CO6160309A2/es unknown
- 2009-03-19 SV SV2009003191A patent/SV2009003191A/es active IP Right Grant
- 2009-04-01 NO NO20091351A patent/NO20091351L/no not_active Application Discontinuation
- 2009-04-16 MA MA31786A patent/MA30790B1/fr unknown
-
2010
- 2010-06-30 US US12/827,614 patent/US20100267766A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2010504311A (ja) | 2010-02-12 |
EA015974B1 (ru) | 2012-01-30 |
SV2009003191A (es) | 2009-10-27 |
AR062896A1 (es) | 2008-12-10 |
TW200819455A (en) | 2008-05-01 |
NZ575573A (en) | 2011-12-22 |
EP2077837A2 (fr) | 2009-07-15 |
UY30604A1 (es) | 2008-05-02 |
WO2008037881A3 (fr) | 2008-05-22 |
BRPI0717100A2 (pt) | 2013-10-15 |
FR2906251A1 (fr) | 2008-03-28 |
MX2009003083A (es) | 2009-04-02 |
US7776880B2 (en) | 2010-08-17 |
WO2008037881A2 (fr) | 2008-04-03 |
KR20090080947A (ko) | 2009-07-27 |
GT200900061A (es) | 2010-06-21 |
AU2007301880A1 (en) | 2008-04-03 |
TN2009000082A1 (en) | 2010-08-19 |
NO20091351L (no) | 2009-06-22 |
CO6160309A2 (es) | 2010-05-20 |
US20090258899A1 (en) | 2009-10-15 |
ZA200901850B (en) | 2010-06-30 |
EA200970312A1 (ru) | 2009-12-30 |
US20100267766A1 (en) | 2010-10-21 |
CR10658A (es) | 2009-06-24 |
FR2906251B1 (fr) | 2008-11-07 |
CA2663080A1 (fr) | 2008-04-03 |
PE20081376A1 (es) | 2008-11-07 |
CN101573113A (zh) | 2009-11-04 |
HN2009000504A (es) | 2011-10-20 |
CL2007002732A1 (es) | 2008-04-18 |
IL197500A0 (en) | 2009-12-24 |
MEP10109A (en) | 2011-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA30790B1 (fr) | Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique | |
MA30792B1 (fr) | DERIVES DE 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE | |
MA31572B1 (fr) | DERIVES DE 6-CYCLOAMINO-3-(PYRIDIN-4-YL)IMIDAZO[1, 2-b]-PYRIDAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE | |
MA32248B1 (fr) | Dérivés polysubstitues de 6-heteroaryle-imidazo[1,2-a]pyridines, leur préparation et leur application en thérapeutique | |
MA27897A1 (fr) | Compose de glucocorticosteroide specifique presentant une active anti-inflammatoire | |
SI20691B (sl) | Triciklični inhibitorji poli(ADP-riboza) polimeraz | |
MA27390A1 (fr) | Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique | |
RU2011139132A (ru) | Азотсодержащие конденсированные гетероциклические соединения и их применение в качестве ингибиторов продукции бета-амилоида | |
NO20041580L (no) | Pyrimidinforbindelse og medisinsk preparat derav | |
JP2015522650A5 (fr) | ||
AR046297A1 (es) | Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo | |
MA27455A1 (fr) | Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique | |
RS52838B (en) | PHENOXIMETHYL HETEROCYCLIC COMPOUNDS | |
JP2007530637A5 (fr) | ||
EA200970705A1 (ru) | Новые фармацевтические композиции | |
ATE530187T1 (de) | Pharmazeutische zubereitungen mit nk1-rezeptor- antagonisten und natriumkanalblockern | |
MA33320B1 (fr) | Derives de rifamycine | |
EP1634874A4 (fr) | Derive d'imidazolidine | |
HRP20140409T1 (hr) | Derivat imidazola sa strukturom prolinskog prstena | |
MA32057B1 (fr) | Derives d'imtoazo [1,2-a] pyridine-2-carboxamides,leur préparation et leur application en thérapeutique | |
MA27732A1 (fr) | Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
MY165634A (en) | Pyrazole compounds having therapeutic effect on multiple myeloma | |
MA27545A1 (fr) | Nouveaux dérivés de benzothiadiazines fluorées, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
MA32060B1 (fr) | Dérivés de n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, leur préparation et leur application en thérapeutique | |
IT1196406B (it) | Derivati tetraciclici dell'indolo |